Cybersecurity: Redefining ‘Defect’ for Small OEMs

Author:

Using an unordered list, summarize the following article with between 4 and 8 key points.
Compliance used to feel like a polite suggestion, a set of “best practices” you could eventually get around to doing once the Series A landed. But in 2026, those days are gone. The era of voluntary cybersecurity guidance hasn’t just ended; it’s been obliterated by the hardline enforcement of Section 524B.

For a small OEM, a cybersecurity gap isn’t just a “tech issue” anymore—it is a critical failure point, a structural flaw every bit as catastrophic as a leaking valve or a corrupted algorithm. While the giants in our industry have the luxury of dedicated “Cyber-RA” teams, startups are still asking engineers to wear four hats at once. This resource chasm is widening, and frankly, it’s becoming a liability that can’t be ignored. Why risk the heart of your innovation on a preventable regulatory stumble?

Section 524B: Decoding the RTA Reality

The FDA’s definition of a “cyber device” is deceptively simple: if it runs software, connects to the internet, and could be vulnerable to a breach, you are officially on the hook. This isn’t a drill. The agency is increasingly using its “refuse to accept” (RTA) power as a first-line filter to keep insecure hardware out of patients’ hands. You need to view your software bill of materials (SBOM) as a digital nutrition label—a transparent, granular breakdown of every dependency in your stack.

To clear the hurdle, your submission must stand on three pillars:

A robust post-market patching plan

Documented proof of a secure product development framework (SPDF)

A detailed software bill of materials

It is a bureaucratic gauntlet, certainly, but one that demands a shift in your fundamental engineering DNA. Can your current process survive a scrutinizing look at your third-party libraries? The RTA isn’t just a delay; for a lean startup, it’s a potential extinction event.

Redefining the ‘Defect’: Why Cyber Is a Quality Issue

The traditional wall between IT security and quality management systems (QMS) hasn’t just cracked; it has completely collapsed. We need to stop treating cybersecurity as a perimeter fence and start seeing it as a core component of product integrity. If your device utilizes a third-party library with a known vulnerability, that isn’t just a “security risk”—it is a latent defect, no different from a brittle plastic casing or a faulty circuit.

This shift is pivotal because the ripple effects are no longer theoretical. A cyber defect doesn’t just invite a data breach; it triggers a Class I recall the moment it compromises device functionality or patient safety. In the midst of the 2026 mandatory security evolution, “safe by design” is now legally synonymous with “secure by design.”

Is your QMS prepared to document a software patch with the same rigor as a mechanical redesign? Treating security as an afterthought is a precarious gamble that modern regulators simply won’t let you get away with.

The Small OEM Survival Strategy: Lean Compliance

Survival doesn’t require a twenty-person security department, but it does require a “Shift Left” mentality that prioritizes early-stage threat modeling and collaboration. Don’t wait for a high-fidelity prototype to ask the hard questions. If you aren’t identifying vulnerabilities during the initial requirement phase, you are essentially scheduling a costly, high-stress re-engineering session for six months down the road. Why build a house on sand when you can test the soil on day one?

Small teams must also master automated SBOM management to stay lean. There are incredible tools now that track open-source dependencies in real time, effectively serving as an automated sentry for your code. Furthermore, if you are outsourcing your build to a contract manufacturing organization (CMO) or a software firm, you must bake 524B compliance directly into your Statement of Work. It’s a harsh truth, but one you need to hear: you can outsource the labor, but you can never outsource the regulatory liability.

Resilience as a Competitive Advantage

Ultimately, Section 524B shouldn’t be viewed solely as a barrier; it’s a sophisticated filter. The OEMs that master this process today are the ones who will dominate the market tomorrow because they won’t be trapped in a soul-crushing cycle of RTA rejections. They move faster because they build better.

We must treat cybersecurity as a fundamental pillar of product integrity, on par with biocompatibility and electrical safety. When you bake security into the DNA of your device, you aren’t just checking a box for the FDA—you’re building a foundation of trust with the patients who depend on you. Resilience isn’t just a goal; it’s your most potent competitive advantage.

Justin Kozak is the executive VP at Founder Shield, a tech-enabled commercial insurance brokerage. He leads the Life Sciences practice, having 10+ years of experience in risk management with Hub International, PBC, and now Founder Shield. He launched his career with a BS in History from the University of Delaware, where his keen understanding of the past informs his intuition in the insurance world. It’s no surprise that Justin’s specialty is customizing insurance programs for emerging markets with little historical data. He enjoys spending time with his young family and can’t get enough of the Phillies.